Schering-Plough launches asthma therapy for under 12s
This article was originally published in Scrip
Executive Summary
Schering-Plough's once-daily asthma therapy Asmanex Twisthaler 110μg (mometasone furoate inhalation powder), approved for use in children four to 11 years of age, has been launched in the US.